Topics

International Stem Cell - A strong 2018 for the commercial business

07:58 EDT 1 May 2019 | FinanzNachrichten

International Stem Cell (ISCO) reported strong FY18 revenues of $11.1m, up 48.7% compared with 2017 mainly due to the biomedical business, which had revenues of $9.3m, up 78.4% year-on-year. The pr...

Original Article: International Stem Cell - A strong 2018 for the commercial business

NEXT ARTICLE

More From BioPortfolio on "International Stem Cell - A strong 2018 for the commercial business"

Quick Search

Relevant Topic

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...